CapsoVision, Inc. Common Stock Total Liabilities
CapsoVision, Inc. Common Stock total liabilities. Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has total liabilities worth $5.40 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See CapsoVision, Inc. Common Stock defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of CapsoVision, Inc. Common Stock (2023–2025)
Total liabilities of CapsoVision, Inc. Common Stock from 2023 to 2025. This chart illustrates how CapsoVision, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
CapsoVision, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dongguan Chitwing Technology Co Ltd
SHE:002855
|
China | CN¥1.38 Billion |
|
Jing Jin Electric Technologies Co Ltd
SHG:688280
|
China | CN¥2.42 Billion |
|
Bank Bukopin Tbk
JK:BBKP
|
Indonesia | Rp78.54 Trillion |
|
Lanpec Technologies Ltd
SHG:601798
|
China | CN¥1.29 Billion |
|
medmix AG
SW:MEDX
|
Switzerland | CHF536.50 Million |
|
Third Point Investors Limited
LSE:TPOU
|
UK | $2.02 Million |
|
Atria Oyj A
HE:ATRAV
|
Finland | €562.70 Million |
|
Annil Co Ltd
SHE:002875
|
China | CN¥433.86 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down CapsoVision, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CV current and non-current assets.
Liquidity & Leverage Metrics
CapsoVision, Inc. Common Stock Total Liabilities Ratios Explained
CapsoVision, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CapsoVision, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CapsoVision, Inc. Common Stock (2023–2025)
The table below shows the annual total liabilities of CapsoVision, Inc. Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.90 Million | -96.65% |
| 2024-12-31 | $146.31 Million | +11.37% |
| 2023-12-31 | $131.37 Million | -- |
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more